FI97809B - Rekombinantti-DNA-molekyyli, joka koodaa kudosperäisen plasminogeenin aktivaattorin (TPA) analogia - Google Patents
Rekombinantti-DNA-molekyyli, joka koodaa kudosperäisen plasminogeenin aktivaattorin (TPA) analogiaInfo
- Publication number
- FI97809B FI97809B FI882922A FI882922A FI97809B FI 97809 B FI97809 B FI 97809B FI 882922 A FI882922 A FI 882922A FI 882922 A FI882922 A FI 882922A FI 97809 B FI97809 B FI 97809B
- Authority
- FI
- Finland
- Prior art keywords
- tpa
- analogs
- recombinant dna
- plasminogen activator
- tissue plasminogen
- Prior art date
Links
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 title abstract 5
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 title abstract 5
- 229960000187 tissue plasminogen activator Drugs 0.000 title abstract 5
- 108020004511 Recombinant DNA Proteins 0.000 title abstract 2
- 102000053602 DNA Human genes 0.000 title 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000013613 expression plasmid Substances 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81160785A | 1985-12-20 | 1985-12-20 | |
| US81160785 | 1985-12-20 | ||
| US90948286A | 1986-09-19 | 1986-09-19 | |
| US90948286 | 1986-09-19 | ||
| US8602684 | 1986-12-12 | ||
| PCT/US1986/002684 WO1987003906A1 (en) | 1985-12-20 | 1986-12-12 | Tissue plasminogen activator (tpa) analogs |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI882922L FI882922L (fi) | 1988-06-17 |
| FI882922A0 FI882922A0 (fi) | 1988-06-17 |
| FI97809B true FI97809B (fi) | 1996-11-15 |
| FI97809C FI97809C (fi) | 1997-02-25 |
Family
ID=27123502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI882922A FI97809C (fi) | 1985-12-20 | 1988-06-17 | Rekombinantti-DNA-molekyyli, joka koodaa kudosperäisen plasminogeenin aktivaattorin (TPA) analogia |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP0231624B1 (fi) |
| JP (1) | JPH0659223B2 (fi) |
| KR (2) | KR950000303B1 (fi) |
| AT (1) | ATE85081T1 (fi) |
| AU (1) | AU600463B2 (fi) |
| DE (1) | DE3687651T2 (fi) |
| DK (1) | DK431887A (fi) |
| ES (1) | ES2053449T3 (fi) |
| FI (1) | FI97809C (fi) |
| GR (1) | GR3007280T3 (fi) |
| NO (1) | NO176921C (fi) |
| WO (1) | WO1987003906A1 (fi) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA869626B (en) * | 1985-12-23 | 1987-10-28 | Chiron Corp | Peptide plasminogen activators |
| DE3682891D1 (de) * | 1986-02-17 | 1992-01-23 | Stichting Centraal Lab | Gewebeplasminogen-aktivator-mutant, dafuer kodierende rekombinante genetische information und verfahren zur herstellung dieser mutanten, deren verwendung und pharmazeutische zusammensetzungen. |
| AU7282687A (en) * | 1986-03-28 | 1987-10-20 | Gabriel Alvarado-Urbina | Protein analogues of tissue plasminogen activator |
| US5047241A (en) * | 1986-07-11 | 1991-09-10 | American Home Products Corporation | Tris-Kringle plasminogen activator with novel K2 insert |
| US5580559A (en) * | 1986-12-05 | 1996-12-03 | Ciba-Geigy Corporation | Hybrid plasminogen activator |
| US5242819A (en) * | 1986-12-05 | 1993-09-07 | Ciba-Geigy Corporation | DNA molecules encoding hybrid proteins of tissue plasminogen activator and urokinase |
| AU1295088A (en) * | 1987-01-30 | 1988-08-24 | American Home Products Corporation | Des-epidermal growth factor plasminogen activators |
| US5149533A (en) * | 1987-06-04 | 1992-09-22 | Zymogenetics, Inc. | Modified t-PA with kringle-/replaced by another kringle |
| SE8702562L (sv) * | 1987-06-18 | 1988-12-19 | Kabigen Ab | Nya fibrinolytiska enzymer |
| US5244676A (en) * | 1987-10-09 | 1993-09-14 | Monsanto Company | Modified tissue plasminogen activator with modified glycosylation site |
| US5037752A (en) * | 1987-10-09 | 1991-08-06 | Monsanto Company | Modified tissue plasminogen activator substituted at cysteine-73 and lysine-277 |
| US4963357A (en) * | 1987-10-09 | 1990-10-16 | Monsanto Company | Tissue plasminogen activator modified by the substitution of Arg for Cys at position 73, methods and pharmaceutical compositions therefor |
| ATE103332T1 (de) * | 1987-10-09 | 1994-04-15 | Monsanto Co | Modifizierter gewebeplasminogenaktivator. |
| US5100666A (en) * | 1987-10-09 | 1992-03-31 | Monsanto Company | Modified tissue plasminogen activator K2K2SP |
| KR970005046B1 (ko) * | 1987-10-29 | 1997-04-11 | 야마노우찌 세이야꾸 가부시끼가이샤 | 개량형 조직 플라스미노겐 활성화 인자 |
| US5648254A (en) * | 1988-01-15 | 1997-07-15 | Zymogenetics, Inc. | Co-expression in eukaryotic cells |
| JPH04500752A (ja) * | 1988-02-05 | 1992-02-13 | ジェンザイム・コーポレーション | 修飾tPAをコードする修飾遺伝子配列、並びにその産物 |
| WO1989007146A1 (en) * | 1988-02-05 | 1989-08-10 | Integrated Genetics, Inc. | Rearranged tissue plasminogen activators and method for producing same |
| AU619803B2 (en) * | 1988-02-05 | 1992-02-06 | Genzyme Corporation | Rearranged tissue plasminogen activators and method for producing same |
| US5270198A (en) * | 1988-05-20 | 1993-12-14 | Genentech, Inc. | DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells |
| US5346824A (en) * | 1988-05-20 | 1994-09-13 | Genentech, Inc. | DNA encoding variants of tissue plasminogen activators and expression vectors and hosts thereof |
| DE3823805A1 (de) * | 1988-07-14 | 1990-01-18 | Basf Ag | Neue polypeptide, ihre herstellung und verwendung |
| DE3825253A1 (de) * | 1988-07-25 | 1990-02-01 | Boehringer Mannheim Gmbh | T-pa-derivat und seine herstellung |
| US5262170A (en) * | 1988-09-02 | 1993-11-16 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells |
| US5714145A (en) * | 1988-09-02 | 1998-02-03 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties |
| DE3836200A1 (de) * | 1988-10-24 | 1990-04-26 | Boehringer Mannheim Gmbh | Domaenenduplikations-muteine des gewebsplasminogen-aktivators (t-pa) |
| WO1990004635A1 (en) * | 1988-10-27 | 1990-05-03 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Thrombolytic agents with modified kringle domains |
| CA2007364A1 (en) * | 1989-01-17 | 1990-07-17 | David J. Livingston | Gene sequences encoding modified residues situated in the protease domain of tpa |
| DE3927865A1 (de) * | 1989-08-23 | 1991-02-28 | Boehringer Mannheim Gmbh | T-pa-mutante gk1l |
| AU664469B2 (en) * | 1992-06-03 | 1995-11-16 | Genentech Inc. | Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
| IL104355A (en) | 1993-01-10 | 2006-08-20 | Yeda Res & Dev | Tnf receptor promoter |
| US5795975A (en) * | 1993-01-10 | 1998-08-18 | Yeda Research And Development Co. Ltd. | TNF receptor promoter |
| US6706504B1 (en) | 1996-11-12 | 2004-03-16 | The Scripps Research Institute | Tissue type plasminogen activator (t-PA) variants: compositions and methods of use |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR241654A1 (es) | 1982-05-05 | 1992-10-30 | Genentech Inc | Procedimiento para producir activador de plasminogeno de tejido humano. |
| ZA837173B (en) | 1982-11-08 | 1984-05-30 | Univ Case Western Reserve | Genomic bovine growth hormone |
| US4511502A (en) | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
| US4511503A (en) | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
| DK149786A (da) | 1985-04-04 | 1986-10-04 | Beecham Group Plc | Proteolytisk enzym |
| US4916071A (en) * | 1985-08-14 | 1990-04-10 | American Home Products Corporation | Poly-kringle plasminogen activator |
| NZ217331A (en) * | 1985-08-26 | 1989-05-29 | Lilly Co Eli | Tissue plasminogen activator derivatives and genetically engineered product |
-
1986
- 1986-12-12 AU AU67701/87A patent/AU600463B2/en not_active Ceased
- 1986-12-12 KR KR1019870700754A patent/KR950000303B1/ko not_active Expired - Fee Related
- 1986-12-12 EP EP86309704A patent/EP0231624B1/en not_active Expired - Lifetime
- 1986-12-12 DE DE8686309704T patent/DE3687651T2/de not_active Expired - Fee Related
- 1986-12-12 WO PCT/US1986/002684 patent/WO1987003906A1/en not_active Ceased
- 1986-12-12 AT AT86309704T patent/ATE85081T1/de active
- 1986-12-12 ES ES86309704T patent/ES2053449T3/es not_active Expired - Lifetime
- 1986-12-12 KR KR870700754A patent/KR880700856A/ko active Granted
- 1986-12-12 EP EP87900529A patent/EP0289508A1/en active Pending
-
1987
- 1987-08-19 DK DK431887A patent/DK431887A/da not_active Application Discontinuation
- 1987-08-20 NO NO873517A patent/NO176921C/no not_active IP Right Cessation
-
1988
- 1988-06-17 FI FI882922A patent/FI97809C/fi not_active IP Right Cessation
-
1993
- 1993-02-15 JP JP5025188A patent/JPH0659223B2/ja not_active Expired - Lifetime
- 1993-03-09 GR GR930400502T patent/GR3007280T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO873517D0 (no) | 1987-08-20 |
| EP0231624A1 (en) | 1987-08-12 |
| KR950000303B1 (ko) | 1995-01-13 |
| GR3007280T3 (fi) | 1993-07-30 |
| NO873517L (no) | 1987-08-20 |
| DE3687651T2 (de) | 1993-06-24 |
| JPH0659223B2 (ja) | 1994-08-10 |
| FI882922L (fi) | 1988-06-17 |
| DE3687651D1 (de) | 1993-03-11 |
| DK431887D0 (da) | 1987-08-19 |
| FI97809C (fi) | 1997-02-25 |
| DK431887A (da) | 1987-08-19 |
| EP0231624B1 (en) | 1993-01-27 |
| KR880700856A (ko) | 1988-04-12 |
| FI882922A0 (fi) | 1988-06-17 |
| NO176921C (no) | 1995-06-21 |
| WO1987003906A1 (en) | 1987-07-02 |
| JPH05344892A (ja) | 1993-12-27 |
| NO176921B (no) | 1995-03-13 |
| ATE85081T1 (de) | 1993-02-15 |
| EP0289508A1 (en) | 1988-11-09 |
| AU6770187A (en) | 1987-07-15 |
| AU600463B2 (en) | 1990-08-16 |
| ES2053449T3 (es) | 1994-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI97809B (fi) | Rekombinantti-DNA-molekyyli, joka koodaa kudosperäisen plasminogeenin aktivaattorin (TPA) analogia | |
| DK288183A (da) | Fremgangsmaade til fremstilling af et oligonucleotidt terapeutisk middel | |
| ATE239789T1 (de) | Chimäre prokoagulierende proteine | |
| RU95115239A (ru) | Аналог эритропоэтина | |
| EP0442961A4 (en) | Hybrid procoagulant proteins | |
| DK75694A (da) | Tumornecrosefaktor og derivater og mutantformer deraf, fremgangsmåde til fremstilling deraf, DNA som koder derfor, replicerbar udtrykkelsesvektor indeholdende DNA'en og celle transformeret dermed samt præparater omfattende tumornecrosefaktoren | |
| FI862756A0 (fi) | Fibroektiner. | |
| DE3682891D1 (de) | Gewebeplasminogen-aktivator-mutant, dafuer kodierende rekombinante genetische information und verfahren zur herstellung dieser mutanten, deren verwendung und pharmazeutische zusammensetzungen. | |
| FI863891A0 (fi) | Menetelmiä sekropiinin ja muiden heterologisten polypeptidien tuottamiseksi bakteeri-isännässä araB-promoottoria käyttäen sekä menetelmissä käyttökelpoisia replikoituvia ekspressiovälineitä, geneettisiä muodostelmia ja bakteereja | |
| ATE71632T1 (de) | Cdns und gen fuer menschliches angiogenin (angiogenesis-faktor) und expression. | |
| CA2091102A1 (en) | Microsomal triglyceride transfer protein | |
| GR1000172B (el) | Βελτιωσεις εις η εν σχεσει προς τις σωματοστατινες. | |
| DK453782A (da) | Dna-sekvenser, rekombinant plasmid samt anvendelser deraf | |
| NZ234453A (en) | Recombinant dna encoding urate oxidase, and vector, host, protein and pharmaceutical compositions associated therewith | |
| NO179754C (no) | Fremgangsmåte for fremstilling av en t-PA-analog, DNA-sekveks som koder for t-PA-analogen, ekspresjonsvektor omfattende DNA-sekvensen samt vertscelle omfattende denne | |
| WO1996003506A3 (en) | Analog of haemophilus hin47 with reduced protease activity | |
| IL80562A0 (en) | Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it | |
| ES2240971T3 (es) | Genes supresores de tumores, proteinas codificadas por ellos y uso de dichos genes y proteinas. | |
| NO179874C (no) | Fremgangsmåte for fremstilling av en t-PA-analog, DNA-sekvens som koder for t-PA-analogen, samt ekspresjonsvektor omfattende DNA-sekvensen og vertcelle omfattende denne | |
| FI925359A0 (fi) | Kloning och expression av dna-molekyler, som kodar foer arabinandegraderande enzymer av svampursprung | |
| ATE309359T1 (de) | Epil/plazentin | |
| CA2002403A1 (en) | Injury-stimulated dna-sequence from solanum tuberosum and its use | |
| ES2059801T3 (es) | Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas. | |
| DE69532109D1 (de) | Expression heterologer proteine in abgeschwächten bakterien mittels des htra-promotors | |
| NO895154L (no) | Fremgangsmaate ved fremstilling av et protein eller polypeptid, en dna-sekvens som koder for polypeptidet, en mikroorganisme som inneholder dna-sekvensen samt polypeptidet ogdets anvendelse som et farmasoeytisk preparat. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Name/ company changed in application |
Owner name: PHARMACIA & UPJOHN COMPANY |
|
| BB | Publication of examined application | ||
| MM | Patent lapsed |
Owner name: PHARMACIA & UPJOHN COMPANY |